论文部分内容阅读
目的探讨冠心病慢性心力衰竭患者室性心律失常的临床治疗。方法将我院2015年4月~2016年1月收录的86例冠心病慢性心力衰竭,患者均合并室性心律失常,按照电脑随机数字滚动组合法均分为治疗A组和对照B组,对照B组43例给予常规措施进行治疗,治疗A组43例患者在对照B组的常规措施基础上采用盐酸胺碘酮治疗,观察比对临床两组治疗效果。结果治疗A组总疗效率为100%(43/43),对照B组的治疗总疗效率为79.07%(34/43),比对差异意义清晰(P<0.05);而治疗期间获得的治疗A组的用药反应不良发生率为4.65%(2/43)显著低于对照B组的25.58%(11/43),比对差异均可见显著统计学专业意义(P<0.05)。结论联合给予参松养心胶囊与盐酸胺碘酮治疗冠心病慢性心力衰竭室性心律失常患者效果明显,服药期间反应不良情况也较少,对此病预后具有重要的改善作用。
Objective To investigate the clinical treatment of ventricular arrhythmia in patients with chronic heart failure of coronary heart disease. Methods From April 2015 to January 2016, 86 cases of chronic heart failure with coronary heart disease were included in our hospital. All patients were complicated with ventricular arrhythmia, and were divided into treatment A group and control group B according to random number rolling combination method. Group B, 43 patients given conventional measures for treatment, treatment A group of 43 patients in the control group B based on the conventional measures with amiodarone hydrochloride treatment, the clinical observation of the two groups compared to the treatment effect. Results The total effective rate of treatment group A was 100% (43/43), while that of control group B was 79.07% (34/43), the difference was significant (P <0.05); while the treatment obtained during treatment The incidence of adverse reactions in group A was 4.65% (2/43), which was significantly lower than that in control group B (25/58) (11/43). There was significant statistical significance (P <0.05) in the differences between the two groups. Conclusions The combined administration of Shensongyangxin Capsule and amiodarone hydrochloride in patients with ventricular arrhythmia of chronic heart failure of coronary heart disease has obvious effect and few adverse reactions during the medication, which has an important effect on the prognosis of this disease.